1. Topical Diclofenac, an Efficacious Treatment for Osteoarthritis: A Narrative Review

   • Frédérique Bariguian Revel
   • Marina Fayet
   • Martina Hagen

   Review Open access 21 February 2020 Pages: 217 - 236

   

2. The Impact of Comorbidity on Patient-Reported Outcomes in Psoriatic Arthritis: A Systematic Literature Review

   • Juan D. Cañete
   • Jose Antonio Pinto Tasende
   • Rubén Queiro

   Review Open access 08 April 2020 Pages: 237 - 257

   

3. Review Article: Is Wnt Signaling an Attractive Target for the Treatment of Osteoarthritis?

   • Rik J. Lories
   • Silvia Monteagudo

   Review Open access 10 April 2020 Pages: 259 - 270

   

4. Psoriatic Arthritis and Diabetes Mellitus: A Narrative Review

   • Giacomo Dal Bello
   • Paolo Gisondi
   • Giampiero Girolomoni

   Review Open access 18 April 2020 Pages: 271 - 285

5. Depression in Psoriatic Arthritis: Dimensional Aspects and Link with Systemic Inflammation

   • Ashish J. Mathew
   • Vinod Chandran

   Review Open access 22 April 2020 Pages: 287 - 300

6. Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study

   • Ennio Lubrano
   • Fabio Massimo Perrotta
   • Antonio Marchesoni

   Original Research Open access 15 February 2020 Pages: 301 - 310

   

7. Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data

   • Hirohito Shimizu
   • Hisanori Kobayashi
   • Yutaka Ishii

   Original Research Open access 29 February 2020 Pages: 311 - 325

   

8. Repository Corticotropin Injection for Active Rheumatoid Arthritis Despite Aggressive Treatment: A Randomized Controlled Withdrawal Trial

   • Roy Fleischmann
   • Daniel E. Furst
   • Richard Brasington

   Original Research Open access 17 March 2020 Pages: 327 - 344

   

9. Real-World Persistence with Tocilizumab Compared to Other Subcutaneous Biologic Disease-Modifying Antirheumatic Drugs Among Patients with Rheumatoid Arthritis Switching from Another Biologic

   • Jennie H. Best
   • Steven C. Vlad
   • Ibrahim Abbass

   Original Research Open access 29 March 2020 Pages: 345 - 355

   

10. Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

    • Dimitrios A. Pappas
    • Taylor Blachley
    • Joel M. Kremer

    Original Research Open access 30 March 2020 Pages: 357 - 369

    

11. Golimumab as the First-, Second-, or at Least Third-Line Biologic Agent in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Ankylosing Spondylitis: Post Hoc Analysis of a Noninterventional Study in Germany

    • Klaus Krüger
    • Gerd Rüdiger Burmester
    • Matthias H. Thomas

    Original Research Open access 17 April 2020 Pages: 371 - 382

    

12. Biologic Disease-Modifying Antirheumatic Drug Prescription Patterns for Rheumatoid Arthritis Among United States Physicians

    • Emma Sullivan
    • Jim Kershaw
    • Susan Boklage

    Original Research Open access 21 April 2020 Pages: 383 - 400

    

13. Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases

    • Hermine Leroi
    • Valérie Badot
    • Chantal Roggeman

    Original Research Open access 02 May 2020 Pages: 401 - 413

    

14. Use and Switching of Biologic Therapy in Patients with Non-Radiographic Axial Spondyloarthritis: A Patient and Provider Survey in the United States

    • Atul Deodhar
    • David Sandoval
    • Theresa Hunter

    Brief Report Open access 23 April 2020 Pages: 415 - 423